article thumbnail

MAPS Is Pushing For FDA Approval Of MDMA-Assisted Therapy

Veriheal

MAPS Public Benefit Corporation (PBC), an arm of the Multidisciplinary Association for Psychedelic Studies , has made big strides recently encouraging the Food and Drug Administration (FDA) to consider approving MDMA, also known as molly or ecstasy, for MDMA-assisted therapy.

Therapy 109
article thumbnail

Emerge Law Group (OR): PSILOCYBIN THERAPY FOR PATIENTS WITH ADVANCED ILLNESS IN OREGON

Cannabis Law Report

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. Adult Oregonians will be able to access psilocybin therapy under the PSA beginning in January 2023; patients with advanced illness are among those who may benefit from this therapy.

Therapy 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mind Medicine Australia: International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021

Cannabis Law Report

International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021. International Psychedelic Therapies Summit 2021 MMA - Brief Outline 20102021. We are delighted to extend an invitation to you and your colleagues to join us ONLINE in November 2021. Here’s their full press release as a PDF.

Therapy 52
article thumbnail

McConnell Misleads on Marijuana

NORML

Some opponents of marijuana policy reform have manipulated the Speaker’s comments to imply that she was opining that cannabis therapy has been proven specifically to be successful for the treatment of COVID-19. The post McConnell Misleads on Marijuana appeared first on NORML.

Marijuana 246
article thumbnail

Harvard Is Launching America’s First Psychedelics Law and Policy Center

SpeedWeed

Harvard Law School is planning to open the first US policy center focused on the legalization and regulation of psychedelics like psilocybin, MDMA, and LSD. . Harvard’s new center will be the first to focus solely on psychedelics policy and laws rather than research, though. View original article.

Policy 52
article thumbnail

Federal Marijuana Reclassification Is on the Horizon

CannaMD

The recommendation by the FDA and HHS to reclassify marijuana as a Schedule III substance marks a pivotal shift in federal drug policy, acknowledging its medical benefits and potential for lower abuse.

DEA 52
article thumbnail

The UFC Knocks Out THC from its Anti-Doping Policy

Veriheal

Although many of these athletes did not consume cannabis prior to games, fights, and other competitions but rather in their own free times, it did not matter as cannabis has been listed in many of the leagues’ anti-doping and drug policies since their inception. A Statement Regarding the Changes. Athletes That Have Come Forward.

Policy 59